The Value of 68Ga-FAPI PET/CT in Detecting Recurrent and Metastatic Lesions in Patients with Thyroid Cancer After Surgery
NCT06800768 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2025-01-30
Summary
This study aims to investigate the value of 68Ga-FAPI PET/CT in detecting recurrent and metastatic lesions in patients with thyroid cancer after surgery.
Conditions
Sponsors & Collaborators
-
Ruijin Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-02-01
- Primary Completion
- 2030-01-31
- Completion
- 2030-01-31
Countries
- China
Study Locations
More Related Trials
-
68Ga-FAPI PET/CT in Malignant Tumors
NCT05034146 ·Status: RECRUITING ·Phase: NA
-
Comparison of 68Ga-DOTA-FAPI-46 and 68Ga-DOTA-2P(FAPI)2 PET/CT in Patients With Various Types of Cancer
NCT04941872 ·Status: COMPLETED ·Phase: NA
-
68Ga-TCR-FAPI PET/CT in Patients With Various Types of Cancer
NCT06084767 ·Status: RECRUITING ·Phase: NA
-
The Function of PET Molecular Imaging Targeting Fibroblast Activation Protein in the Hepatobiliary Malignancies
NCT05264688 ·Status: UNKNOWN
-
68Ga-FAPI PET/CT in Patients With Various Types of Cancer
NCT04499365 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Comparison of FDG and FAPI in Patients With Various Types of Cancer
NCT04416165 ·Status: RECRUITING ·Phase: NA
-
Diagnostic Significance of FDG PET/CT Dynamic Imaging in Detecting Metastatic Lymph Nodes With Papillary Thyroid Cancer.
NCT03830242 ·Status: UNKNOWN ·Phase: NA
-
18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma
NCT04588064 ·Status: COMPLETED ·Phase: NA
-
Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer
NCT05392205 ·Status: COMPLETED ·Phase: NA
-
The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis.
NCT06597526 ·Status: RECRUITING
-
Role of FAPI PET/MR Combined With Gadoxetate Disodium in Assessing Hepatic Malignancies
NCT06287411 ·Status: RECRUITING
-
68Ga-FAPI-FS PET/CT and PET/MR in Pancreatic Cancer
NCT05875753 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Application of FDG Combined With FAPI PET Dual Imaging in the Diagnosis and Staging of Oropharyngeal and Laryngeal Cancer
NCT06304155 ·Status: RECRUITING
-
Diagnosis of Metastatic Tumors on 68Ga-FAPI-RGD PET-CT and Radioligand Therapy With 177Lu-FAPI-RGD
NCT06638034 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence
NCT05856409 ·Status: RECRUITING
-
Study on the Value of Non-invasive Dual-Pet Information in Subtype of Metastatic Breast Cancer
NCT04758416 ·Status: UNKNOWN
-
Trop2-targeted immunoPET Imaging of Solid Tumors
NCT06851663 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
18F-FAPI-RGD PET/CT in Various Tumor Types
NCT06094530 ·Status: RECRUITING
-
Clinical Study of 18F-FAPI-RGD in Breast Tumors
NCT05976620 ·Status: COMPLETED
-
Heterogeneity of 68Ga-FAPI Uptake As Imaging Biomarker in T-DXd Treatment for Brain Metastasis of HER2 Positive Breast Cancer
NCT06797622 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of [68Ga]Ga-NOTA-RG2 PET Imaging in the Diagnosis of Hepatocellular Carcinoma
NCT06148155 ·Status: RECRUITING ·Phase: NA
-
68Ga-FAPI-RGD PET/CT for Dual Integrin αvβ3 and FAP-targeted Imaging in Patients With Various Types of Cancer and Compared With 18F-FDG
NCT05543317 ·Status: COMPLETED ·Phase: NA
-
Performance of 18F-FDG Micro-PET-CT in the Assessment of Surgical Margins in Head and Neck Cancer
NCT07285564 ·Status: RECRUITING ·Phase: NA
-
Exploring the Value of 18F-AlF-FAPI PET/CT in Assessing the Activity of Thyroid Eye Disease
NCT06359795 ·Status: RECRUITING ·Phase: NA
-
Clinical Study of TROP-2 PET/CT for Noninvasive Diagnosis of Solid Tumors
NCT06203574 ·Status: RECRUITING ·Phase: NA